Gentamicin
- Product NDC
- 63323-173
- 11-digit product format
- 633230173
- Labeler code
- 63323
- Product ID
- 63323-173_9f48c9f7-08fd-4652-911c-c2c221a34ed3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GENTAMICIN
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA062366
- Marketing category
- ANDA
- Marketing start
- 2004-11-29
- Substance
- GENTAMICIN SULFATE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gentamicin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GENTAMICIN SULFATE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8X7386QRLV |
| Rxcui | 1870676 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-173-01 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | | 8 |
| 63323-173-02 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 8 |
| 63323-173-41 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | | 4 |
| 63323-173-94 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 4 |
| 63323-173-95 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 3 |
| 63323-173-95 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-173 | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC
] | 8 | Current NDC, Legacy NDC, 2 package rows | 20231215_be5b414e-d598-4721-80ee-5836156ad210.zip |
| 63323-173 | GENTAMICIN (GENTAMICIN) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC
] | 4 | Current NDC, Legacy NDC, 2 package rows | 20240106_8bdeef7f-ad8e-46e0-a872-e945eae51d68.zip |
| 63323-173 | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241017_63413469-c676-48a3-a945-7d2489b535ef.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-173-01 | 63323017301 | 2 mL in 1 VIAL | 2 ml | | | | | Historical |
| 63323-173-02 | 63323017302 | 25 VIAL in 1 TRAY (63323-173-02) / 2 mL in 1 VIAL (63323-173-01) | 25 vial | 2004-11-29 | 0000-00-00 | No | No | Current |
| 63323-173-41 | 63323017341 | 2 mL in 1 VIAL | 2 ml | | | | | Historical |
| 63323-173-94 | 63323017394 | 25 VIAL in 1 TRAY (63323-173-94) / 2 mL in 1 VIAL (63323-173-41) | 25 vial | 2004-11-29 | 0000-00-00 | No | No | Current |
| 63323-173-95 | 63323017395 | 25 VIAL in 1 TRAY (63323-173-95) / 2 mL in 1 VIAL | 25 vial | 2004-11-29 | 0000-00-00 | No | No | Current |